Clinical Trials in San Diego

Showing 6761-6780 of 14,679 trials

Ibrutinib and Azacitidine for Treatment of Higher Risk Myelodysplastic Syndrome

NCT02553941

This phase Ib trial studies the side effects and best dose of ibrutinib when given together with azacitidine in treating patients with myelodysplastic syndrome that is likely to occur or spread (higher risk) and who were previously treated or untreated and unfit for or refused intense therapy. Ibrutinib and azacitidine may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth.

Chronic Myelomonocytic Leukemiade Novo Myelodysplastic SyndromePreviously Treated Myelodysplastic Syndrome+2 more

Brian Jonas21 participantsStarted May 2016

Los Angeles, California, United States • Orange, California, United States • Sacramento, California, United States +2 more locations

COMPLETEDNA< 1 mile

Trial to Reduce Sitting Time in Postmenopausal Latina Women at Increased Risk for Heart Disease

NCT02905929

Project 2 of the University of California, San Diego (UCSD) American Heart Association (AHA) Women's Health Program will assess 3-month changes in sitting time, standing time, physical activity and blood pressure in a randomized control trial (RCT). This 2-arm RCT will occur in the community with post menopausal Latina women (N=250) who spend at least 8 hrs/day sitting and have increased risk for cardiovascular disease through high BMI and other cardiometabolic risk factors. Women will be identified through the San Ysidro Health Center and assessed at the South Bay Latino Research Center.

Sedentary Lifestyle

University of California, San Diego254 participantsStarted Apr 2017

Chula Vista, California, United States • San Diego, California, United States

Ibrutinib and Azacitidine for Treatment of Higher Risk Myelodysplastic Syndrome

Trial to Reduce Sitting Time in Postmenopausal Latina Women at Increased Risk for Heart Disease

Find Trials by Condition in San Diego

Biomarker Strategies for Medication-Enhanced Cognitive Training in Schizophrenia

Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Newly Diagnosed, Previously Untreated Multiple Myeloma

Therapy for Pediatric Relapsed or Refractory Precursor B-Cell Acute Lymphoblastic Leukemia and Lymphoma

Study to Evaluate the Safety and Efficacy of High Dose Intravenous Immune Globulin (IVIG) Plus Standard Medical Treatment (SMT) Versus SMT Alone in Participants in Intensive Care Unit (ICU) With Coronavirus Disease (COVID-19)

Mifepristone Treatment of Alcohol Use Disorder

A Study of the Safety and Pharmacokinetics of Apixaban Versus Vitamin K Antagonist (VKA) or Low Molecular Weight Heparin (LMWH) in Pediatric Subjects With Congenital or Acquired Heart Disease Requiring Anticoagulation

A Phase III Study to Evaluate the Port Delivery System With Ranibizumab Compared With Monthly Ranibizumab Injections in Participants With Wet Age-Related Macular Degeneration

Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Efficacy of Evixapodlin (Formerly GS-4224) in Participants With Advanced Solid Tumors

Open Label Extension to Assess the Safety of Long-Term Treatment With Ampion for Severe Osteoarthritis (OA) of the Knee

TH9507 Extension Study in Patients With HIV-Associated Lipodystrophy

Study of Vadadustat in Hemodialysis Participants With Anemia Switching From Epoetin Alfa

P1 Single and Multiple Ascending Dose (SAD/MAD) Study of IV QPX7728 Alone and Combined With QPX2014 in NHV

Effects of Therapy With Sulfamylon® 5% Topical Solution Compared to a Historical Control Group

Dysport® Adult Lower Limb Spasticity Study

Safety and Efficacy of Nerinetide (NA-1) in Subjects Undergoing Endovascular Thrombectomy for Stroke

(VOYAGER) Study of Avapritinib vs Regorafenib in Patients With Locally Advanced Unresectable or Metastatic GIST

A Study of ALRN-6924 for the Prevention of Chemotherapy-induced Side Effects (Chemoprotection)

Does the Cap Increase the Finding of Polyps When Water Exchange Colonoscopy is Used